BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3326469)

  • 1. A novel type of c-myc translocation in a T lymphoma cell line.
    Aghib D; Ottolenghi S; Rocchi M; Guerrasio A; Saglio G
    Ann N Y Acad Sci; 1987; 511():338-42. PubMed ID: 3326469
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome translocations in B and T cell neoplasias.
    Showe LC; Croce CM
    Semin Hematol; 1986 Oct; 23(4):237-44. PubMed ID: 3535082
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis.
    Dalla-Favera R; Lombardi L; Pelicci PG; Lanfrancone L; Cesarman E; Neri A
    Ann N Y Acad Sci; 1987; 511():207-18. PubMed ID: 2830825
    [No Abstract]   [Full Text] [Related]  

  • 4. N segment insertion and region-directed somatic hypermutation in a kappa gene of a t(2;8) chromosomal translocation.
    Klobeck HG; Combriato G; Zachau HG
    Nucleic Acids Res; 1987 Jun; 15(12):4877-88. PubMed ID: 3110741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.
    Cory S
    Adv Cancer Res; 1986; 47():189-234. PubMed ID: 3096089
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathogenesis of Burkitt's lymphoma.
    Magrath I
    Adv Cancer Res; 1990; 55():133-270. PubMed ID: 2166998
    [No Abstract]   [Full Text] [Related]  

  • 7. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
    Larsen CJ; Mecucci C; Leroux D
    Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.
    Selvanayagam P; Blick M; Narni F; van Tuinen P; Ledbetter DH; Alexanian R; Saunders GF; Barlogie B
    Blood; 1988 Jan; 71(1):30-5. PubMed ID: 3275475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt lymphoma cells by triple-color fluorescence in situ hybridization.
    Ried T; Lengauer C; Cremer T; Wiegant J; Raap AK; van der Ploeg M; Groitl P; Lipp M
    Genes Chromosomes Cancer; 1992 Jan; 4(1):69-74. PubMed ID: 1377011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. t(2;18) and t(18;22) variant chromosomal translocations in B cell malignancies.
    Bertheas MF; Bachy M; Magaud JP; Rimokh R; Vasselon C; Berger F; Oriol PC; Jaubert J; Reynaud J; Brizard CP
    Leuk Lymphoma; 1992 Oct; 8(3):197-200. PubMed ID: 1490147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.
    De Jong D; Voetdijk BM; Beverstock GC; van Ommen GJ; Willemze R; Kluin PM
    N Engl J Med; 1988 May; 318(21):1373-8. PubMed ID: 3285208
    [No Abstract]   [Full Text] [Related]  

  • 14. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
    Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
    Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
    Pezzella F; Mason DY
    Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma associated with a novel complex karyotype including t(2;3)(q21;q27), t(8;14)(q24;q32) and t(14;18)(q32;q21).
    Nakayama S; Yokote T; Iwaki K; Takayama A; Tsuji M; Hanafusa T
    Br J Haematol; 2013 Mar; 160(5):569. PubMed ID: 23205706
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma.
    Sainati L; Montaldi A; Stella M; Putti MC; Zanesco L; Basso G
    Br J Haematol; 1990 Aug; 75(4):621-2. PubMed ID: 2207016
    [No Abstract]   [Full Text] [Related]  

  • 19. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. myc oncogenes: activation and amplification.
    Alitalo K; Koskinen P; Mäkelä TP; Saksela K; Sistonen L; Winqvist R
    Biochim Biophys Acta; 1987 Apr; 907(1):1-32. PubMed ID: 3552050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.